Norwalk virus edible vaccine - Boyce Thompson Institute for Plant Research

Drug Profile

Norwalk virus edible vaccine - Boyce Thompson Institute for Plant Research

Latest Information Update: 19 Jan 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Boyce Thompson Institute for Plant Research
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Norwalk virus infections

Most Recent Events

  • 05 Sep 2000 The Boyce Thompson Institute is seeking a corporate partner for continued development of the edible Norwalk virus vaccine (http://bti.cornell.edu/)
  • 28 Aug 2000 A phase I trial has been added to the adverse events section and the Viral Infections immunogenicity section
  • 21 Jun 2000 Phase-I clinical trials for Norwalk virus infections in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top